Envista Holdings Co. (NYSE:NVST) Shares Sold by Amalgamated Bank

Amalgamated Bank decreased its holdings in Envista Holdings Co. (NYSE:NVSTGet Rating) by 3.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 112,014 shares of the company’s stock after selling 3,568 shares during the quarter. Amalgamated Bank owned 0.07% of Envista worth $5,456,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in NVST. CI Investments Inc. grew its holdings in shares of Envista by 8,922.2% during the 1st quarter. CI Investments Inc. now owns 812 shares of the company’s stock valued at $40,000 after acquiring an additional 803 shares in the last quarter. Covestor Ltd bought a new stake in shares of Envista during the fourth quarter valued at approximately $43,000. Elequin Capital LP bought a new stake in shares of Envista during the first quarter valued at approximately $64,000. Parkside Financial Bank & Trust boosted its stake in Envista by 32.7% in the first quarter. Parkside Financial Bank & Trust now owns 2,481 shares of the company’s stock valued at $121,000 after acquiring an additional 612 shares during the last quarter. Finally, Wakefield Asset Management LLLP acquired a new stake in shares of Envista during the first quarter worth $231,000.

Analysts Set New Price Targets

Several analysts recently commented on NVST shares. TheStreet downgraded shares of Envista from a “b” rating to a “c+” rating in a report on Friday, June 17th. Evercore ISI lowered their price objective on shares of Envista to $44.00 in a research report on Tuesday, August 9th. The Goldman Sachs Group lowered their price objective on shares of Envista from $58.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, July 21st. Piper Sandler upgraded shares of Envista from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $40.00 to $46.00 in a research report on Monday, August 29th. Finally, Robert W. Baird cut shares of Envista from an “outperform” rating to a “neutral” rating and lowered their price objective for the stock from $54.00 to $46.00 in a research report on Tuesday, June 14th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Envista has a consensus rating of “Moderate Buy” and an average target price of $46.86.

Envista Stock Up 1.5 %

Shares of NYSE NVST opened at $34.83 on Tuesday. The firm has a market cap of $5.69 billion, a PE ratio of 20.73, a P/E/G ratio of 1.36 and a beta of 1.54. Envista Holdings Co. has a 12-month low of $33.84 and a 12-month high of $52.03. The company’s fifty day simple moving average is $38.49 and its 200 day simple moving average is $41.48. The company has a quick ratio of 0.88, a current ratio of 1.11 and a debt-to-equity ratio of 0.22.

Envista (NYSE:NVSTGet Rating) last issued its earnings results on Wednesday, August 3rd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.02. The business had revenue of $645.80 million for the quarter, compared to analyst estimates of $657.55 million. Envista had a net margin of 11.86% and a return on equity of 8.26%. As a group, sell-side analysts forecast that Envista Holdings Co. will post 1.98 earnings per share for the current fiscal year.

About Envista

(Get Rating)

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.

Featured Articles

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTGet Rating).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.